← Open Payments lookup

PAUL OTTESON: Open Payments

NPI 1982030987 · GRIMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$482 in 22 payments from 11 companies in 2025. Trend: 2023 $109 · 2024 $295 · 2025 $482

Food & beverage: $397Education: $85
CompanyPaymentsAmount
Janssen Biotech, Inc.5$165
Regeneron Healthcare Solutions, Inc.3$54
Novartis Pharmaceuticals Corporation2$50
Lilly USA, LLC2$37
Galderma Laboratories, L.P.2$36
Amgen Inc.2$35
E.R. Squibb & Sons, L.L.C.2$34
SUN PHARMACEUTICAL INDUSTRIES INC.1$26
LNHC, Inc1$16
Arcutis Biotherapeutics, Inc.1$15

Products named: TREMFYA, DUPIXENT, Rhapsido, NEMLUVIO, OTEZLA, Sotyktu, ILUMYA, TALTZ.

Industry payments across IA — which companies pay providers there.